http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1248967-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-62
filingDate 1983-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f0f36a93ba1e714e6a5facfc2086e75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d73b4e49912023d11def852c426c8522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d10b89c2e522159b31a76d9a478192d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f2b33686df80e5d39d0b5764117a20
publicationDate 1989-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1248967-A
titleOfInvention Process for the preparation of a phenylalkylaminoethylsalicylamide
abstract ABSTRACT There are disclosed a process for producing (-)-5-(R)-1-hydroxy-2-[(R)-1-methyl-3-phenylpropyl amino-ethyl salicylamide and its acid addition salts in high yields which does not require chromatography, and impor-tant intermediates in this process. The process is stereoselective for the desired (R,R) amine; a preferred embodiment includes the steps of (1) reaction of an N-[(R)-protected]-(R)-1-methyl-3-phenyl-propylamine with a 4-0-protected 2-bromo-3-carbamoyl-ace-tophenone to produce the corresponding R,R-glycyl-benza-mide, (2) reduction to produce a mixture of S,R,R;R,R,R--hydroxybenzamides, (3) removal of the protecting groups, (4) resolution of the deprotected product and, if de-sired, conversion to the free R,R -amine or to another salt. In this process, the selection of particular N-pro-tecting groups has a very favourable effect, especially in steps (2) and (3).
priorityDate 1982-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410570511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416150075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448212476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4459029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415829807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451541399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416604284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454339353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12362977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71301631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421377479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410472318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410539310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20722760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448941027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53472086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448630398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11667949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451363760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12858289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86632114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211

Total number of triples: 80.